Newborn Screening Market to be Worth $2.49 Billion by 2030

Ever since its introduction in the early 1960s, newborn screening has been carried out using traditional technologies such as tandem mass spectrometry and biochemical testing, among others. These technologies are effective and reliable, however, the emergence of advanced technologies has improved the accuracy of results. Next-generation sequencing (NGS) and artificial intelligence (AI) are two of the most researched technologies in the newborn screening industry.